Our thought leadership in action
Our Cencora teams and leaders from the managed care pharmacy community convened in Las Vegas at AMCP Nexus 2024.
Explore some of our expert contributions, posters and related content that showcased our commitment to helping our biopharma partners accelerate product success.
Explore some of our expert contributions, posters and related content that showcased our commitment to helping our biopharma partners accelerate product success.
Insights from the conference
Cynthiya Ruban, Director of Digital Solutions at Cencora and Charlie Dragovich, Senior Director and Client Strategist at Cencora, shared insights with Managed Healthcare Executive while at the conference.
Webinar:
Diagnosing the health (policy) of our nation: The impact of November’s elections
Join us for an insightful webinar with reimbursement policy expert Corey Ford that will explore the critical impact of the upcoming November general election on federal health policy heading into 2025 and beyond. As the landscape shifts, understanding the implications of election outcomes on health policy becomes essential for stakeholders across the healthcare spectrum.
Register now to gain valuable knowledge and prepare for the evolving health policy landscape!
Register now to gain valuable knowledge and prepare for the evolving health policy landscape!
Don’t miss our award-winning research during the Expo
- Evaluation of healthcare decision-maker perspectives on artificial intelligence workflow implementation in healthcare and its utilization in the formulary decision-making process
- How does pre-approval information exchange (PIE) affect formulary decision-making?
- Optimizing the timing of pre-approval information exchange (PIE) for oncology product, products for rare diseases, and cell and gene therapies (CGTs)
- Opportunities for product differentiation and evidence generation with a focus on health disparities information in the Academy of Managed Care Pharmacy Format for Formulary Submissions (AMCP Format) version 5.0
- Real-world regorafenib use among patients with advanced gastrointestinal stromal tumors (aGIST) in the United States (US)
- Demographics and Healthcare Resource Utilization in Patients in the United States with Alpha-1 Antitrypsin Deficiency who are treated with Glassia (alpha-1 proteinase inhibitor)
- Practice Efficiency and Total Costs Associated with Treating Relapsed or Refractory Diffuse Large B-Cell Lymphoma with Epcoritamab and Glofitamab from an Institutional Perspective
- The role of patient experience data in payer decision-making
FormularyDecisions® delivers unrivaled opportunities for biopharma companies to reach out to, and connect with, payers
Increase engagement
Biopharma companies who fully take advantage of the FormularyDecisions platform and all its features enjoy greater levels of engagement with the payer community, helping build a stronger level of awareness and relationships with payers.
Drive awareness
In the current landscape, it’s harder than ever for biopharma companies to get in-person meetings with payers. FormularyDecisions enables easy outreach to, and engagement with, these critical stakeholders.
Monitor competition
With unparalleled insights into how their product compares with direct competitors, biopharma companies get a full view of the landscape in the therapeutic space, and learn what they can do to stay ahead of the curve.
Leverage and understand insights
With direct real-time feedback from payers on a product, biopharma companies can get a better understanding of payer perceptions and refine their information so it resonates better with payers
Managed Care Network Forum
Get exclusive access to payer insights at the Managed Care Network (MCN) Forum. Our exclusive event is for biopharma companies can get a better understanding of payer perceptions and refine their information so it resonates better with payers focused on market access, commercial development, HEOR, and clinical/medical affairs and brings together a broad mix of national and regional payers/formulary decision makers from our proprietary MCN.
Introducing PayerPulse Express
In the fast-paced landscape of biopharma, PayerPulse Express offers swift, indispensable market insights, delivering a competitive edge and showcasing product value in ways that will resonate with healthcare decision makers. Within 24-48 hours, you can access critical data to prevent costly errors and guide strategic decisions. Take advantage of tailored, data-driven insights to enhance your product's lifecycle and uncover payer perspectives on your most critical issues. Reach out to us today for well-informed choices with PayerPulse Express.
Health Economics & Market Access Solutions
Optimize market access, awareness, and outcomes through expert guidance with a proven track record of success. Our leading team of value experts transforms evidence, policy insights, and market intelligence into effective global market access strategies helping clients effectively navigate today’s complex healthcare landscape.
Event recap:
AMCP Nexus 2024